Sunmax Biotechnology Co., Ltd. (TPEX: 4728)
Health Care · Biotechnology · TW
NT$399.00
-0.50% today · -3.2% 1Y
Sunmax Biotechnology Co., Ltd. (TPEX: 4728) operates in the Biotechnology industry within the Health Care sector. The company is valued at $681.17M and employs 30 people.
Over the last twelve months the share price has lost 3.2%, trading between 350.00 and 431.50.
Tweenvest scores Sunmax Biotechnology Co., Ltd. across four factors: quality 78/100, value 31/100, growth 75/100, dividend 60/100. Its strongest factor is quality.
4728 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $681.17M
- Revenue (TTM)
- $63.69M
- P/E
- 30.07
- EPS
- 13.27
- Dividend yield
- 3.02%
- Beta (5Y)
- -0.13
- 52-week high
- NT$431.50
- 52-week low
- NT$350.00
- Avg volume (3M)
- —
- Shares outstanding
- 54.46M
- Employees
- 30
- Next earnings
- —
About Sunmax Biotechnology Co., Ltd.
Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd. functions as a biomedical enterprise. The company specializes in the development, manufacturing, and commercialization of collagen-based medical devices across Taiwan and mainland China. Its diverse product line encompasses Porcogen, a sterile, purified collagen solution valuable for medical device applications, tissue engineering, and research. Sunmax also supplies various dermal fillers, including the Sunmax collagen implant series (I-Plus, I) and FACIALGAIN collagen implants (with and without lidocaine), engineered for correcting facial aesthetic concerns such as wrinkles. For dental procedures, they provide specialized collagen-based solutions like Sunmax collagen dental bone grafts, membranes, and granules, used for augmenting or reconstructing the alveolar ridge, extraction sockets, and in periodontics. Additionally, the Sunmax collagen bone graft matrix serves as a bone void filler that naturally resorbs and facilitates new bone formation during recovery. The company's offerings extend to skincare products, such as Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and a general collagen skincare line, all designed for post-dermal filler treatment aftercare.
- ISIN
- TW0004728001
- Founded
- 2001
- Listed since
- Jan 10, 2012
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.00 | +0.08% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.45 | +0.05% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.74 | -0.02% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €909.60 | +3.46% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $157.49 | -0.84% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.